Active ingredient and patch for treating hyperplasia and rheumatic diseases

Abstract

The invention relates to a traditional Chinese medicinal composition. An active ingredient for treating hyperplasia and rheumatic diseases comprises the following raw materials in parts by weight: 40-60 parts of olibanum, 50-60 parts of myrrh, 15-20 parts of Ephedra equisetina, 45-50 parts of Ligusticum wallichii, 60-70 parts ofSaposhnikovia divaricata, 40-50 parts of Drynaria fortunei, 30-40 parts of Momordica cochinchinensis,20-30 parts of Angelica dahurica, 30-40 parts of Rhizoma Et Radix Notopterygii, 25-30 parts of Radix angelicae pubescentis,40-50 parts of Chaenomeles speciosa fruit, 40-50 parts of Phryma leptostachya, 40-50 parts of Cyathula officinalis, 30-40 parts of Radix Aconiti, 5-20 parts of resina draconis 1, and 15 parts of Herba Asari. The invention also relates to a patch for treating hyperplasia and rheumatic diseases. The active ingredient provided by the invention has effects of softening hard masses, dispelling blood stasis, relaxing muscles and tendons, activating the collaterals, relieving inflammation and dispersing pathogenic wind, and can be used for timely and effective treatment of cervical hyperplasia, lumbar disc herniation hyperplasia, spinal canal stenosis, knee hyperplasia, synovitis, rheumatism, rheumatoid, and other diseases.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition. Background technique [0002] Cervical spondylosis, also known as cervical syndrome, is a general term for cervical osteoarthritis, hypertrophic spondylitis, cervical nerve root syndrome, and cervical disc herniation. It is a disease based on degenerative pathological changes. Mainly due to long-term cervical strain, bone hyperplasia, or intervertebral disc herniation, ligament thickening, cervical spinal cord, nerve root or vertebral artery are compressed, and a series of clinical syndromes of dysfunction appear. It is manifested as cervical disc degeneration itself and its secondary pathological changes, such as vertebral instability and loosening; nucleus pulposus protrusion or prolapse; bone spur formation; ligament hypertrophy and secondary spinal canal stenosis, etc., which stimulate or compress the Adjacent nerve roots, spinal cord, vertebral arteries, and cervical sympathetic...

AI Technical Summary

Problems solved by technology

However, due to differences in the location, size, diameter of the spinal canal, pathological characteristics, body condition, and individual sensitivity of the nucleus pulposus, the clinical manifestations also have certain differences.